What’s New

Two reign supreme while many fail to follow

October 20, 2020

Both the British-based Oxford-AstraZeneca and American-based Pfizer are in the running to have Phase 3 human trials of their COVID-19 vaccine ready by the end of 2020.

September the turn and toil of biases

September 29, 2020

In a world riddled with noise and confusion, one can easily get lost. We reckon at this stage that you have heard more than a few stories about how poorly South Africa’s economy is doing and how we will never return to our former rainbow-nation glory.

August economics

September 1, 2020

Usually, those familiar with equity markets cringe their teeth when August comes along.

Markets, trade and tantrums

August 25, 2020

At the start of last week, European markets were down more than 1% as investors were fretting the re-emergence of the coronavirus in Europe.

Markets, Trade and Tantrums

August 25, 2020

At the start of last week, European markets were down more than 1% as investors were fretting the re-emergence of the corona virus in Europe.

July: Covid Confusion

August 4, 2020

In July, South Africans heard that they would be placed under a stricter level 3 lockdown. In one of his addresses to the nation, President Cyril Ramaphosa announced that the government would restrict the movement and consumption of South Africans.

Prescribed Assets

July 22, 2020

Prescribed assets have been on the government’s agenda since it appeared on their election manifesto in 2019.

Alternatives to Cash

July 17, 2020

The interest rate on cash reduced by 44% during the past year. This has had a significant impact on investors seeking stable interest income.

Insurance in the time of COVID-19

July 8, 2020

In the current economic times, we are all facing uncertainties. But we believe that now more than ever, it is important for you to consider the risks associated with everyday living.

Subscribe To Newsletter

Quick Contact

Your Partner in Financial Services